252 related articles for article (PubMed ID: 23327801)
1. The role of the IL-23/IL-17 axis in the pathogenesis of Graves' disease.
Zheng L; Ye P; Liu C
Endocr J; 2013; 60(5):591-7. PubMed ID: 23327801
[TBL] [Abstract][Full Text] [Related]
2. Effect of IL-21 on the Balance of Th17 Cells/Treg Cells in the Pathogenesis of Graves' Disease.
Tan Y; Chen W; Liu C; Zheng X; Guo A; Long J
Endocr Res; 2019 Nov; 44(4):138-147. PubMed ID: 31055979
[TBL] [Abstract][Full Text] [Related]
3. Regulatory T cells but not T helper 17 cells are modulated in an animal model of Graves' hyperthyroidism.
Zhou J; Bi M; Fan C; Song X; Yang R; Zhao S; Li L; Li Y; Teng W; Shan Z
Clin Exp Med; 2012 Mar; 12(1):39-46. PubMed ID: 21544672
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of IL-37 in patients with Graves' disease and its contribution to suppression of proinflammatory cytokines production in peripheral blood mononuclear cells.
Li Y; Wang Z; Yu T; Chen B; Zhang J; Huang K; Huang Z
PLoS One; 2014; 9(9):e107183. PubMed ID: 25226272
[TBL] [Abstract][Full Text] [Related]
5. Increased IL-21/IL-21R expression and its proinflammatory effects in autoimmune thyroid disease.
Guan LJ; Wang X; Meng S; Shi LF; Jiang WJ; Xiao L; Shi XH; Xu J; Zhang JA
Cytokine; 2015 Apr; 72(2):160-5. PubMed ID: 25647271
[TBL] [Abstract][Full Text] [Related]
6. Imbalance of Th17/Treg in Different Subtypes of Autoimmune Thyroid Diseases.
Li C; Yuan J; Zhu YF; Yang XJ; Wang Q; Xu J; He ST; Zhang JA
Cell Physiol Biochem; 2016; 40(1-2):245-252. PubMed ID: 27855396
[TBL] [Abstract][Full Text] [Related]
7. Elevated follicular helper T cells and expression of IL-21 in thyroid tissues are involved in the pathogenesis of Graves' disease.
Zhang J; Ren M; Zeng H; Guo Y; Zhuang Z; Feng Z; Yan H; Xu M; Liang W; Yang C; Cheng H; Ding H; Yan L
Immunol Res; 2015 Jun; 62(2):163-74. PubMed ID: 25894310
[TBL] [Abstract][Full Text] [Related]
8. MST-4 and TRAF-6 expression in the peripheral blood mononuclear cells of patients with Graves' disease and its significance.
Guo A; Tan Y; Liu C; Zheng X
BMC Endocr Disord; 2017 Feb; 17(1):11. PubMed ID: 28219358
[TBL] [Abstract][Full Text] [Related]
9. Circulating MicroRNAs in Graves' Disease in Relation to Clinical Activity.
Hiratsuka I; Yamada H; Munetsuna E; Hashimoto S; Itoh M
Thyroid; 2016 Oct; 26(10):1431-1440. PubMed ID: 27610819
[TBL] [Abstract][Full Text] [Related]
10. Spiking expression of mu-crystallin mRNA during treatment with methimazole in patients with graves' hyperthyroidism.
Suzuki S; Takei M; Nishio S; Inaba H; Sato A; Yamazaki M; Shinomiya K; Hashizume K
Horm Metab Res; 2009 Jul; 41(7):548-53. PubMed ID: 19280551
[TBL] [Abstract][Full Text] [Related]
11. [Role of Treg/Th17 cells and related cytokines in Graves' ophthalmopathy].
Lv M; Shen J; Li Z; Zhao D; Chen Z; Wan H; Hao B
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Dec; 34(12):1809-13. PubMed ID: 25537908
[TBL] [Abstract][Full Text] [Related]
12. Methimazole therapy in Graves' disease influences the abnormal expression of CD69 (early activation antigen) on T cells.
Corrales JJ; López A; Ciudad J; Mories MT; Miralles JM; Orfao A
J Endocrinol; 1997 Dec; 155(3):491-500. PubMed ID: 9487994
[TBL] [Abstract][Full Text] [Related]
13. Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking.
Salvi M; Pedrazzoni M; Girasole G; Giuliani N; Minelli R; Wall JR; Roti E
Eur J Endocrinol; 2000 Aug; 143(2):197-202. PubMed ID: 10913938
[TBL] [Abstract][Full Text] [Related]
14. Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease.
Nanba T; Watanabe M; Inoue N; Iwatani Y
Thyroid; 2009 May; 19(5):495-501. PubMed ID: 19415997
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of costimulatory molecules (CD28-CTLA-4/B7) expression on chosen mononuclear cells in adolescents with Graves' disease during methimazole therapy].
Bossowski A; Stasiak-Barmuta A; Urban M; Rinderle C
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):93-101. PubMed ID: 15504312
[TBL] [Abstract][Full Text] [Related]
16. Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease.
Salvi M; Girasole G; Pedrazzoni M; Passeri M; Giuliani N; Minelli R; Braverman LE; Roti E
J Clin Endocrinol Metab; 1996 Aug; 81(8):2976-9. PubMed ID: 8768861
[TBL] [Abstract][Full Text] [Related]
17. Methimazole upregulates T-cell-derived cytokines without improving the existing Th1/Th2 imbalance in Graves' disease.
Kocjan T; Wraber B; Kocijancic A; Hojker S
J Endocrinol Invest; 2004 Apr; 27(4):302-7. PubMed ID: 15233546
[TBL] [Abstract][Full Text] [Related]
18. In vitro production of interferon-gamma by peripheral blood from patients with Graves' disease, Hashimoto's thyroiditis and rheumatoid arthritis.
Matsubayashi S; Akasu F; Kasuga Y; Snow K; Keystone E; Volpé R
Clin Exp Immunol; 1990 Oct; 82(1):63-8. PubMed ID: 1976464
[TBL] [Abstract][Full Text] [Related]
19. Increased peripheral RORα and RORγt mRNA expression is associated with acute-on-chronic hepatitis B liver failure.
Qi ZX; Wang LY; Fan YC; Zhang JJ; Li T; Wang K
J Viral Hepat; 2012 Nov; 19(11):811-22. PubMed ID: 23043388
[TBL] [Abstract][Full Text] [Related]
20. Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy.
Antonelli A; Rotondi M; Fallahi P; Romagnani P; Ferrari SM; Barani L; Ferrannini E; Serio M
Clin Endocrinol (Oxf); 2006 Feb; 64(2):189-95. PubMed ID: 16430719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
